NEW YORK (360Dx) – Quidel said after the close of the market on Monday that the US Food and Drug Administration has cleared the company's Sofia Lyme FIA test to run on the Sofia 2 Fluorescent Immunoassay Analyzer.

As a result , Quidel can now market the assay on the next-generation version of the Sofia instrument in the US.